Could stem cells save sight? new trial tests umbilical cord therapy for eye disease

NCT ID NCT05909488

Not yet recruiting Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether stem cells from umbilical cord tissue can safely slow vision loss in people with retinitis pigmentosa, an inherited eye disease. Thirty participants will receive one of two doses injected around the eye and be monitored for six months. The main goals are to check safety and measure changes in vision and eye structure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord stem cells
What this could lead to: If it works, this could slow vision loss and help preserve sight in people with retinitis pigmentosa.
What could go wrong: This is an early combined Phase 2/3 trial with only 30 people. It primarily checks safety, and it's unknown if the stem cells will actually improve vision. There are risks like infection or eye inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinitis pigmentosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINITIS PIGMENTOSA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

RSUP Dr. Sardjito

Yogyakarta, DI Yogyakarta, 55284, Indonesia

Contact

Contact

Contact Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.